Stephan Cordogan

80 posts

Stephan Cordogan

Stephan Cordogan

@stephan_cdgn

Statistical Geneticist @nucleusgenomics

New York City Katılım Mart 2025
194 Takip Edilen126 Takipçiler
Sabitlenmiş Tweet
Stephan Cordogan
Stephan Cordogan@stephan_cdgn·
I’m thrilled to have led efforts to develop Nucleus Origin, the most predictive family of PRS to-date, explaining over 20% of liability-scale variance in Alzheimer's, coronary artery disease, prostate cancer, type 1 and type 2 diabetes!
medRxiv@medrxivpreprint

Within- and Between-Family Validation of Nine Polygenic Risk Scores Developed in 1.5 Million Individuals: Implications for IVF, Embryo Selection, and Reduction in Lifetime Disease Risk medrxiv.org/cgi/content/sh… #medRxiv

English
2
3
16
12K
Stephan Cordogan retweetledi
UK Biobank
UK Biobank@uk_biobank·
✅ The UK Government has today granted access to half a million UK Biobank participants' coded GP data for health research. This change will dramatically increase the power of UK Biobank's dataset to advance the diagnosis, treatment and management of conditions handled by GPs.
UK Biobank tweet media
English
3
26
68
5.9K
Stephan Cordogan retweetledi
Veera Rajagopal 
Veera Rajagopal @doctorveera·
An interesting preprint from Alkes Price's lab shows that GWAS effect sizes' relationship with minor allele frequency (MAF) is better explained by African MAF than European MAF. We know that rare variants have larger effect sizes, which is a reflection of negative selection. Disease-causing deleterious variants are kept at lower frequencies by natural selection. However, allele frequency of a variant is influenced not only by natural selection, but also by other factors like genetic drift caused bottleneck events. MAFs of all non-African populations are influenced by out-of-Africa bottleneck effects. Such frequency changes reflect drift, not disease biology. In this work, Rossen et al. empirically show that in fact African MAF estimates better explain GWAS effect sizes than European MAF, even when the GWAS is performed in European populations. These results suggest that many downstream GWAS analyses—such as heritability estimation, fine-mapping, and polygenic risk prediction—may be systematically misspecified when relying solely on European-derived MAFs. Incorporating African MAFs is likely to yield more accurate effect-size modeling, even for GWAS performed entirely in European populations. Rossen et al. medRxiv 2026 medrxiv.org/content/10.648…
English
4
46
193
51.9K
Stephan Cordogan retweetledi
Abdel Abdellaoui
Abdel Abdellaoui@dr_appie·
Here is another version of the Figure I made to summarize the study, showing both trait-level and factor-level genetic correlations
Abdel Abdellaoui tweet media
Abdel Abdellaoui@dr_appie

New @Nature study maps the genetic risk shared across psychiatric disorders. In News & Views, I discuss what it means when that genetic risk overlaps with normal traits, including education-related outcomes. News & Views: nature.com/articles/d4158… Study: nature.com/articles/s4158…

English
8
28
129
26.2K
Stephan Cordogan retweetledi
Boyang Fu
Boyang Fu@Boyang1995·
🧬 Do genetic variants interact in humans? For years, the answer was “probably, but we lacked solid statistical evidence.” We now bring one of the strongest pieces of evidence to date. Thrilled to share our latest work, FAME, now at Nature Genetics: nature.com/articles/s4158…
English
13
57
279
73.4K
Stephan Cordogan
Stephan Cordogan@stephan_cdgn·
They don't provide details on how the scores are validated. Their Liability R2 confidence intervals are of similar size across all diseases regardless of disease frequency, which is impossible without extreme cherrypicking of individuals (which would certainly introduce bias). The CIs of common diseases like Hypertension should be much smaller than rare diseases like Alzheimers, and we address this as well. Their models aren't public either, so there's no way to test.
English
1
1
8
7.4K
Sichu Lu
Sichu Lu@lu_sichu·
@KianSadeghi5 @herasight oh this is spicy you know what i don't know if i looked at this white paper but i had thought maybe the herasight did this(authors confirmed to me they didn't but i am confused about how functional priors are used in bayesrc and i did not follow up on that myself)
Sichu Lu tweet media
English
2
0
3
1.2K
Sichu Lu
Sichu Lu@lu_sichu·
Honestly I don't see why it matters one way or another(you can't qt your friends post? Is your only defense from the allegations that your opponents are wicked and being paid. You can show you didn't copy the herasight pgs easily enough. Provide the code or at least the results of the analysis then? Let a third party test your pgs under a confidentiality agreement(I think most labs can do this)
Crémieux@cremieuxrecueil

Kian is now engaging in slander by alleging that I've been paid to promote my friend's post showing that Nucleus has engaged in fraud. I haven't. I just genuinely hate fraud. And I have a long history on this account of calling it out. No one would ever need to pay me to do it.

English
4
1
25
6.1K
Josie Zayner
Josie Zayner@josiezayner·
This is not what you do when accusations are leveed against your biotech company. Instead of responding to actual claims they slander my homie @cremieuxrecueil because he retweeted something? Many of us retweeted the takedown because we think that your company is sketchy
Kian Sadeghi@KianSadeghi5

Everything levied unto Nucleus by @sichuan_mala is false. Worse than false, it appears to be architected by a competitor that has repeatedly published misstatements and inaccuracies. Sichuan is compromised. But it gets worse. I have been informed that @cremieuxrecueil — race “scientist” in chief — has been paid off by the competitor to promote this nonsense against Nucleus. For the independent scientists repeating this libel, I would encourage you to do more diligence on who you are aligning yourself with. Our scientific team will issue a point by point response. Unfortunately, though, this isn’t about science. It’s a concerted attempt to cancel Nucleus on the backs of our successful campaign and efforts to build + advance the industry, which benefits the very people who are attacking us. To the the mob trying to cancel Nucleus: Keep tweeting. Stay mad. We’ll keep building and serving patients. P.S. We won the injunction. Link below.

English
5
5
104
20.9K
Sheel Mohnot
Sheel Mohnot@pitdesi·
This… is not eugenics
English
36
1
220
67.2K
Stephan Cordogan
Stephan Cordogan@stephan_cdgn·
@RuxandraTeslo If you don't like to pile on, why did you uncritically endorse the post by @sichuan_mala? A simple Google or UK-Biobank showcase search would have disproven many of his technical points, and the rest are addressed here: x.com/stephan_cdgn/s…
Stephan Cordogan@stephan_cdgn

I'm the lead author on Nucleus Origin. All substantive technical claims about the Nucleus Origin preprint made by @sichuan_mala are false. I outline why, point-by-point, in the link below.

English
1
0
6
4.9K
Ruxandra Teslo 🧬
Ruxandra Teslo 🧬@RuxandraTeslo·
I don't like to pile on people, but, as someone writing abt fertility and IVF, I believe this is a particularly sensitive area of biotech, with parents putting all their hopes for their future child. Taking advantage of these dreams is particularly bad.
English
5
5
185
20K
Anshul Kundaje
Anshul Kundaje@anshulkundaje·
@eade_bengard @RTNJO3 Their science is much stronger, novel and open than anything Nucleus has released + I have raised questions I had about Herasight's work here & they have actively responded.
English
2
0
1
104
Harsh Sharma
Harsh Sharma@harshv_0314·
I'm hopeful for a future where we can get rid of genetic disease, but all of what Nucleus Genomics is described as doing in this article just sets the entire field + scientific community back several years. Worth reading.
四川麻辣燙@sichuan_mala

I've just written a new post raising a series of concerns about Nucleus Genomics, a company that offers embryo selection services based on polygenic scores for couples undergoing IVF. I was shocked by the degree to which Nucleus's work is obviously plagiarized or simply wrong.

English
3
0
3
440
Stephan Cordogan
Stephan Cordogan@stephan_cdgn·
I'm the lead author on Nucleus Origin. All substantive technical claims about the Nucleus Origin preprint made by @sichuan_mala are false. I outline why, point-by-point, in the link below.
Stephan Cordogan tweet media
English
8
5
44
53.2K
Stephan Cordogan retweetledi
Kian Sadeghi
Kian Sadeghi@KianSadeghi5·
Everything levied unto Nucleus by @sichuan_mala is false. Worse than false, it appears to be architected by a competitor that has repeatedly published misstatements and inaccuracies. Sichuan is compromised. But it gets worse. I have been informed that @cremieuxrecueil — race “scientist” in chief — has been paid off by the competitor to promote this nonsense against Nucleus. For the independent scientists repeating this libel, I would encourage you to do more diligence on who you are aligning yourself with. Our scientific team will issue a point by point response. Unfortunately, though, this isn’t about science. It’s a concerted attempt to cancel Nucleus on the backs of our successful campaign and efforts to build + advance the industry, which benefits the very people who are attacking us. To the the mob trying to cancel Nucleus: Keep tweeting. Stay mad. We’ll keep building and serving patients. P.S. We won the injunction. Link below.
English
31
7
140
588.2K
Stephan Cordogan retweetledi
Kian Sadeghi
Kian Sadeghi@KianSadeghi5·
BREAKING Have your best baby. Today, @nucleusgenomics announces the largest genetic optimization campaign ever. > Full station-blitz of Broadway Lafayette > 1,000+ street ads across NYC > 1,000+ subway car ads > Dozens of Urban panels throughout Soho
Kian Sadeghi tweet media
English
26
21
205
165K
Stephan Cordogan retweetledi
Nucleus Genomics
Nucleus Genomics@nucleusgenomics·
Anyone can have a taller, smarter, and healthier baby with IVF+. But the broader public is not yet aware what is now possible with advanced genetics. So we've launched the "Have Your Best Baby" campaign to bridge that gap. The future of modern family planning is here.
Nucleus Genomics tweet media
English
2
4
20
2.6K
Stephan Cordogan retweetledi
steve hsu
steve hsu@hsu_steve·
I'm specifically referring to journalists suggesting that we cannot predict disease risks and other complex traits from DNA alone. x.com/hsu_steve/stat… The fact that we can is NOT in question among actual researchers in the field. There are hundreds of papers per year now published on polygenic scores for human complex traits. Replication of the results has been performed in different ancestry groups, raised on different continents, in different cultures, in different decades. Ability to predict which sibling is higher risk for diabetes or taller or higher IQ has also been demonstrated across many cohorts. Whether you "like the feelz" of embryo selection is not the same thing as understanding how polygenic prediction using training sets of ~million genomes and health records works. Journalists should be careful about the distinction.
Emma Waters@emlwaters

“Ideological” does not mean “whoever disagrees with me.” @hsu_steve Where did the WSJ err in their reporting? Most companies publish in house, and therefore NOT peer-reviewed data. Who wouldn’t be skeptical, especially when other well-respected researchers are very skeptical.

English
4
9
72
13.1K
Stephan Cordogan retweetledi
Loïc Yengo
Loïc Yengo@LoicYengo·
We are pleased to announce that our new study explaining the missing heritability of many phenotypes using WGS data from ~347,000 UK Biobank participants has just been published in @Nature. Please check out our manuscript here: nature.com/articles/s4158….
English
8
119
412
136K
Stephan Cordogan retweetledi
Arpit Gupta
Arpit Gupta@arpitrage·
Very cool JMP by @ppcreanza: the Gilded Era merger wave didn't kill innovation, it turbo boosted it. Large scale consolidation in early 20th century enabled large industrial labs, lower cost of capital, and more breakthrough patents pierpaolocreanza.github.io/website/creanz…
Arpit Gupta tweet mediaArpit Gupta tweet mediaArpit Gupta tweet mediaArpit Gupta tweet media
English
12
129
547
140K